Berman Capital Advisors’s AbbVie ABBV Stock Holding History

Berman Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$847K	Buy	7,861 +1,004	+15%	+$115K	0.13%	84
2021 Q2	$771K	Buy	6,857 +1,005	+17%	+$113K	0.12%	84
2021 Q1	$633K	Buy	5,852 +824	+16%	+$88.1K	0.13%	83
2020 Q4	$538K	Buy	5,028 +78	+2%	+$7.5K	0.13%	81
2020 Q3	$433K	Buy	4,950 +517	+12%	+$48.7K	0.12%	79
2020 Q2	$435K	Buy	4,433 +1,250	+39%	+$110K	0.11%	77
2020 Q1	$242K	Buy	3,183 +871	+38%	+$74.2K	0.08%	105
2019 Q4	$204K	Buy	2,312 +115	+5%	+$9.55K	0.06%	130
2019 Q3	$166K	Sell	2,197 -166	-7%	-$11.4K	0.05%	151
2019 Q2	$170K	Buy	2,363 +647	+38%	+$50.9K	0.05%	144
2019 Q1	$137K	Buy	1,716 +15	+0.9%	+$1.23K	0.05%	158
2018 Q4	$156K	Buy	+1,701	New	+$150K	0.06%	121
2018 Q3	–	Sell	-2,797	Closed	-$258K	–	108
2018 Q2	$258K	Buy	2,797 +235	+9%	+$23K	0.09%	95
2018 Q1	$242K	Buy	+2,562	New	+$281K	0.09%	91

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berman Capital Advisors's ABBV Position: Q3 2021 in Review

Berman Capital Advisors increased its AbbVie (ABBV) stake by 15% in Q3 2021, buying an estimated $115K and bringing the position to 7,861 shares worth $847K. The position accounts for 0.13% of the portfolio, ranked #84.

Berman Capital Advisors first reported a position in ABBV in Q1 2018 and has held it in 14 quarters since. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Berman Capital Advisors held 7,861 shares of AbbVie worth $847K as of Q3 2021.
Berman Capital Advisors bought 1,004 AbbVie shares in Q3 2021, an estimated $115K.
AbbVie made up 0.13% of Berman Capital Advisors's portfolio in Q3 2021, its #84 holding.
Berman Capital Advisors first reported a position in AbbVie in Q1 2018 and has held it in 14 quarters since.
2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.